Automation Partnerships DiaSorin's collaboration with Inpeco to automate the QuantiFERON IGRA workflow demonstrates a market opportunity to offer end-to-end automated immunodiagnostic solutions. Pitch to large health systems and contract labs to bundle Liaison Nes POC, Simplexa, and automation integration services for higher throughput and reduced manual steps.

Channel Expansion The partnership with McKesson for distribution signals a scalable US channel strategy; there is potential to expand with additional distributors and regional partners to accelerate adoption of Liaison Nes and other platforms in mid-market labs and hospital networks; emphasize co-marketing and training plans to reduce onboarding friction.

Precision Medicine Focus Leadership appointments and focus on precision medicine and companion diagnostics position DiaSorin to co-develop with pharma/biotech and supply clinical trial and diagnostic expansion opportunities; target labs serving biopharma programs and precision medicine initiatives with integrated testing workflows.

Regulatory Ready Portfolio Recent CE-marked launches and collaborations show a rapid, regulatory-ready product cadence in high-throughput TB and fungal diagnostics; opportunities to address public health laboratories, hospital systems, and labs seeking compliant, scalable testing options with LIAISON and Simplexa platforms.

Regional Sales Growth New regional sales leadership for Ireland and Northern Ireland indicates expansion of direct selling in Europe; focus efforts on hospital networks, regional labs, and public health centers to accelerate adoption of Liaison Nes and related immunodiagnostic offerings in these markets.